We assign a fundamental rating of 3 out of 10 to NUVL. NUVL was compared to 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for NUVL as it has an excellent financial health rating, but there are worries on the profitability. NUVL is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

NUVL had negative earnings in the past year.
In the past year NUVL has reported a negative cash flow from operations.
NUVL had negative earnings in each of the past 5 years.
NUVL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

NUVL has a Return On Assets of -38.93%. This is in the better half of the industry: NUVL outperforms 60.19% of its industry peers.
The Return On Equity of NUVL (-45.12%) is better than 68.95% of its industry peers.

		Industry Rank	Sector Rank
ROA	-38.93%
ROE	-45.12%
ROIC	N/A

ROA(3y)-19.01%

ROA(5y)-42.03%

ROE(3y)-20.02%

ROE(5y)-88.07%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NUVL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for NUVL has been increased compared to 1 year ago.
NUVL has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NUVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 37.08 indicates that NUVL is not in any danger for bankruptcy at the moment.
NUVL's Altman-Z score of 37.08 is amongst the best of the industry. NUVL outperforms 94.67% of its industry peers.
NUVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	37.08

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 10.73 indicates that NUVL has no problem at all paying its short term obligations.
NUVL's Current ratio of 10.73 is amongst the best of the industry. NUVL outperforms 84.57% of its industry peers.
A Quick Ratio of 10.73 indicates that NUVL has no problem at all paying its short term obligations.
The Quick ratio of NUVL (10.73) is better than 84.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.73
Quick Ratio	10.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NUVL have decreased strongly by -53.31% in the last year.

EPS 1Y (TTM)-53.31%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-32.81%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NUVL will show a very strong growth in Earnings Per Share. The EPS will grow by 21.20% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-50.14%

EPS Next 2Y-22.88%

EPS Next 3Y-4.29%

EPS Next 5Y21.2%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NUVL. In the last year negative earnings were reported.
Also next year NUVL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.